Ethos Updates

Western Reserve Partners, a division of Citizens Capital Markets, Inc., is pleased to announce that it served as the exclusive financial advisor to Ethos Veterinary Health, LLC (“Ethos” or the “Company”) in its recapitalization by Brown Brothers Harriman Capital Partners (“BBHCP”).

Woburn, Mass., August 24, 2018 –Ethos Veterinary Health (Ethos) has developed a position statement in support of NAVTA’s Veterinary Nurse Initiative (VNI). The initiative by the National Association of Veterinary Technicians in America is aimed at establishing a national credential for Registered Veterinary Nurses (RVN).

WOBURN, Mass. (BUSINESS WIRE) — Ethos Veterinary Health (Ethos), a leading independent veterinary health company, just finalized its third acquisition since December 2017, expanding its presence across the U.S. Integrative Pet Care in Chicago, Veterinary Emergency + Referral Center of Hawaii, in Honolulu, and Atlantic Street Veterinary Hospital Pet Emergency Center in Roseville, CA, have recently joined Ethos. Ethos has significantly expanded

WOBURN, Mass.–(BUSINESS WIRE)–The American College of Veterinary Internal Medicine (ACVIM) has entered into a partnership with VetBloom, the digital learning ecosystem from Ethos Veterinary Health (Ethos). This multifaceted partnership will actualize development of a Virtual Learning Environment for ACVIM and its members and allow collaboration on the development of eLearning modules. In addition, VetBloom will develop an integrated online

BEVERLY, Mass., April 04, 2018 (GLOBE NEWSWIRE) — LexaGene Holdings Inc. (OTCQB:LXXGF) (TSX-V:LXG) (the “Company”), a biotechnology company that develops instrumentation for pathogen detection, announced today that it has entered into collaboration with Ethos Veterinary Health, a veterinary health company with hospitals across the U.S. that provide advanced medical care for pets. This partnership will provide canine urine

WOBURN, Mass.–(BUSINESS WIRE)–Lincoln Memorial University (LMU) and Ethos Veterinary Health (Ethos) have entered into a unique collaborative relationship to advance their shared commitment to improve the profession through innovation in education. The relationship aims to transform learning in the veterinary community by leveraging Ethos’ unique commitment to learning and development and its online learning platform, VetBloom, and the strength

CNA Diagnostics Inc. (“CNAD”) and Ethos Veterinary Health (“Ethos”) are pleased to announce the parties have entered a strategic partnership to develop and distribute a suite of molecular diagnostic tests specifically designed to serve the companion animal market.

FORT COLLINS, Colo.–(BUSINESS WIRE)–VetDC, Inc., the leading veterinary cancer therapeutics company, today announced a new TANOVEA®-CA1 (rabacfosadine for injection) publication in Veterinary & Comparative Oncology. Data from this publication and several new VetDC-sponsored studies was prominently featured in a State of the Art presentation at the Veterinary Cancer Society (VCS) Annual Conference this past weekend in Portland, Oregon,

For veterinarians, this is no more shocking than any other toxin or item that pets can get exposed to. Neither is the location of the exposure, as no town is immune from the opioid crisis. Naloxone is not a new addition to our hospital formularies, as opioids are utilized in anesthesia and pain management protocols, and this agent has long been used to reverse these effects when needed.

DENVER–(BUSINESS WIRE)–Vista Veterinary Specialists (Vista), a 24-hour specialty and emergency hospital located in Sacramento, Calif., joined Ethos Veterinary Health (Ethos) on August 2nd. Vista is the 15th hospital owned and operated by Ethos. “Having Vista onboard adds to our growing set of veterinary hospitals and we are pleased to expand our presence in California,” said Ames Prentiss, CEO of

EXPANDS SERVICE TO ASIA AND FORMS INNOVATIVE PARTNERSHIPS WITH ONCORE EPD AND DAVID LISS, RVT OF VETERINARY TRAINING AND CONSULTING WOBURN, Mass.–(BUSINESS WIRE)–VetBloom, the cutting-edge, continuing education platform from Ethos Veterinary Health (Ethos), continues to rapidly expand its offerings and reach. VetBloom recently formed new partnerships with ONCORE ePD and David Liss, RVT, VTS (ECC, SAIM), CVPM, and

New Opportunity for Rapid Approval of Innovative Therapies for the Animal Health Market WOBURN, Mass. (March 8, 2017) — Animal Clinical Investigation (ACI) and Ethos Veterinary Health (Ethos) have formed a strategic alliance offering a new mechanism to deliver market approval of pharmaceuticals and therapeutics in Animal Health. This relationship offers a unique opportunity for collaboration with organizations